Pfizer Responds to Research Claims
Pfizer
JANUARY 27, 2023
In a limited number of cases when a full virus does not contain any known gain of function mutations, such virus may be engineered to enable the assessment of antiviral activity in cells. A transient decrease in body weight was observed in the nursing offspring of rats administered nirmatrelvir.
Let's personalize your content